Hanmi Pharm Pyeongtaek Bio Plant Receives Top 'P' Grade in Government Process Safety Management Evaluation

Hanmi Pharm Pyeongtaek Bio Plant.

[Asia Economy Reporter Lee Gwan-joo] Hanmi Pharm announced on the 11th that its Pyeongtaek Bio Plant, which recently underwent the Process Safety Management (PSM) audit conducted by the Ministry of Employment and Labor, received the highest grade of 'P (Progressive)'.

PSM is a system established by the government to comprehensively evaluate and manage the safety of workplaces handling hazardous equipment and materials in order to prevent major industrial accidents. The highest grade 'P' awarded to the Pyeongtaek Bio Plant is difficult to obtain, as only 10 out of 620 workplaces in the metropolitan area received it last year. By obtaining the P grade, the facility is recognized as a top-level safety workplace certified by the government, exempted from Ministry of Employment and Labor inspections for the next three years, and allowed to manage safety autonomously.

The Pyeongtaek Bio Plant is Hanmi Pharm’s state-of-the-art biopharmaceutical production base. It has established an optimal environment, health, and safety management system by integrating its self-developed EHS (Environment·Health·Safety) system with the latest IT technologies.

A Hanmi Pharm official stated, "The Pyeongtaek Bio Plant is a cutting-edge factory producing 'Rollontis,' Hanmi’s first global new drug candidate, prioritizing safety above all else and striving to produce high-quality pharmaceuticals through accident-free processes. We will continue to make every effort to establish the Pyeongtaek Bio Plant as a global production base based on safe process management."

This content was produced with the assistance of AI translation services.